NextCell Pharma AB (STO:NXTCL)

NextCell Pharma AB Income Statement

Financials in millions SEK. Fiscal year is September - August.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Operating Revenue	9.98	10.66	10.11	5.59	3.91	3.56
Other Revenue	0.26	0.61	3.84	0.64	0.54	0.6
Revenue	10.24	11.28	13.96	6.23	4.46	4.17
Revenue Growth (YoY)	-24.72%	-19.18%	124.03%	39.82%	6.93%	112.11%
Cost of Revenue	14.29	15.22	11	8.72	9.94	6.77
Gross Profit	-4.06	-3.94	2.96	-2.49	-5.48	-2.6
Selling, General & Admin	33.81	38.22	43.47	31.85	18.84	14.68
Other Operating Expenses	0.29	0.04	0.04	0.22	0.06	0.03
Operating Expenses	36.65	39.23	43.96	32.53	19.34	15.1
Operating Income	-40.7	-43.17	-41	-35.02	-24.82	-17.7
Interest Expense	-0	-0	-0	-0.01	-0.01	-0.01
Interest & Investment Income	0.94	1.21	1.19	0.48	0.27	0.03
Other Non Operating Income (Expenses)	-	-	-	-	-	0
Pretax Income	-39.76	-41.96	-39.81	-34.55	-24.56	-17.68
Net Income	-39.76	-41.96	-39.81	-34.55	-24.56	-17.68
Net Income to Common	-39.76	-41.96	-39.81	-34.55	-24.56	-17.68
Shares Outstanding (Basic)	70	41	34	34	30	20
Shares Outstanding (Diluted)	70	41	34	34	30	20
Shares Change (YoY)	103.17%	18.72%	-	13.05%	53.09%	60.47%
EPS (Basic)	-0.57	-1.03	-1.16	-1.01	-0.81	-0.89
EPS (Diluted)	-0.57	-1.03	-1.16	-1.01	-0.81	-0.89
Free Cash Flow	-38.49	-37.86	-47.92	-40.9	-26.3	-19.75
Free Cash Flow Per Share	-0.55	-0.93	-1.39	-1.19	-0.86	-0.99
Gross Margin	-39.61%	-34.98%	21.19%	-40.03%	-123.08%	-62.39%
Operating Margin	-397.52%	-382.79%	-293.81%	-562.26%	-557.14%	-424.91%
Profit Margin	-388.33%	-372.04%	-285.28%	-554.72%	-551.21%	-424.39%
Free Cash Flow Margin	-375.96%	-335.70%	-343.41%	-656.63%	-590.41%	-473.99%
EBITDA	-38.16	-42.2	-40.55	-34.57	-24.38	-17.31
EBITDA Margin	-	-	-290.60%	-	-	-
D&A For EBITDA	2.55	0.97	0.45	0.46	0.44	0.4
EBIT	-40.7	-43.17	-41	-35.02	-24.82	-17.7
EBIT Margin	-	-	-293.81%	-	-	-
Revenue as Reported	10.24	11.28	13.96	6.23	4.45	4.17

Updated May 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.